AstraZeneca plc (LSE: AZN, NYSE: AZN, OMX: AZN) is an Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries (ICI), as three divisions that were spun off from ICI on 1 June 1993. It is a public company and is listed on the London Stock Exchange, the New York Stock Exchange and the OMX exchange. It is a constituent of the FTS...
more
AstraZeneca plc (LSE: AZN, NYSE: AZN, OMX: AZN) is an Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries (ICI), as three divisions that were spun off from ICI on 1 June 1993. It is a public company and is listed on the London Stock Exchange, the New York Stock Exchange and the OMX exchange. It is a constituent of the FTSE 100 Index.
The company's origins date from 1912, when Atlas Chemical Industries was founded by demerger from DuPont in Wilmington, Delaware, United States, in 1912. Subsequently, Atlas Chemical Industries acquired Stuart Pharmaceuticals (founded by Arthur Hanisch in Pasadena, California, U.S., in 1941) in 1961 before itself being bought by ICI in 1972. In 1993 ICI demerged this pharmaceuticals business, as well as its agrochemicals and specialties businesses, to form Zeneca Group plc.
Astra AB was founded in 1913 by 400 doctors and...
less
